Inventor · disambiguated record
Steven Neville Chatfield
Also filed as: CHATFIELD STEVEN N · CHATFIELD STEVEN NEVILLE
18 granted patents·4 pending applications·393 citations·filing 1993–2009
95Inventor score
Files withGLAXO WELLCOME INC6MEDEVA HOLDINGS BV5ACAMBIS RES LTD2ARCHIMEDES DEV LTD1BURROUGHS WELLCOME CO1
Top patents by PatentIndex Score
22 records- 0191US6391318B1Vaccine compositions including chitosan for intranasal administration and use thereofWEST PHARM SERV DRUG RES LTD·Filed 1998·Granted May 21, 2002·90 cites·17 claims
- 0278US5683700AExpression of recombinant proteins in attenuated bacteriaGLAXO WELLCOME INC·Filed 1995·Granted Nov 4, 1997·41 cites·7 claims
- 0375US6902906B1Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccinesACAMBIS RES LTD·Filed 1999·Granted Jun 7, 2005·34 cites·10 claims
- 0472US6905691B1Vaccines containing attenuated bacteriaCELLTECH PHARMA EUROP LTD·Filed 2000·Granted Jun 14, 2005·7 cites·27 claims
- 0571US7323183B2Vaccine compositions including chitosan for intranasal administration and use thereofARCHIMEDES DEV LTD·Filed 2002·Granted Jan 29, 2008·2 cites·21 claims
- 0671US6699480B2Vaccine compositionsMEDEVA HOLDINGS BV·Filed 2001·Granted Mar 2, 2004·1 cites·12 claims
- 0770US5547664AExpression of recombinant proteins in attenuated bacteriaBURROUGHS WELLCOME CO·Filed 1994·Granted Aug 20, 1996·31 cites·7 claims
- 0867US6488926B1Vaccine compositionsMEDEVA HOLDINGS BV·Filed 1994·Granted Dec 3, 2002·34 cites·22 claims
- 0966US6136606AInfluenza vaccine compositionsMEDEVA HOLDINGS BV·Filed 1996·Granted Oct 24, 2000·27 cites·21 claims
- 1064US5527529AVaccines comprising attenuated salmonella having mutations in the ompr genesWELLCOME FOUND·Filed 1995·Granted Jun 18, 1996·27 cites·8 claims
- 1163US5851519ALive vaccinesGLAXO WELLCOME INC·Filed 1995·Granted Dec 22, 1998·26 cites·13 claims
- 1263US5804194AVaccines containing a salmonella bacteria attenuated by mutation of the htra geneGLAXO WELLCOME INC·Filed 1994·Granted Sep 8, 1998·14 cites·18 claims
- 1360US5770214AVaccines containing salmonella bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathwayGLAXO WELLCOME INC·Filed 1995·Granted Jun 23, 1998·19 cites·12 claims
- 1460US2010322955A1Virulence genes, proteins, and their useCHATFIELD STEVEN NEVILLE·Filed 2009·Application pending·0 cites
- 1556US6048536AVaccine compositionsMEDEVA HOLDINGS BV·Filed 1995·Granted Apr 11, 2000·17 cites·19 claims
- 1652US5980907AVaccines containing bacteria attenuated by mutation of the htrA geneGLAXO WELLCOME INC·Filed 1995·Granted Nov 9, 1999·9 cites·17 claims
- 1749US2004131637A1Salmonella promoter for heterologous gene expressionFiled 2002·Application pending·0 cites
- 1847US2004258709A1Hepatitis B virus polypeptidesMEDEVA EUROP LTD·Filed 2004·Application pending·0 cites
- 1945US2003157121A1Virulence genes, proteins, and their useFiled 2001·Application pending·0 cites
- 2040US6680182B1Expression of recombinant fusion proteins in attenuated bacteriaACAMBIS RES LTD·Filed 1993·Granted Jan 20, 2004·7 cites·15 claims
- 2140US5811105AVaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathwayGLAXO WELLCOME INC·Filed 1995·Granted Sep 22, 1998·6 cites·23 claims
- 2235US6129922AMethods for adjuvant free hepatitis A virus vaccinationMEDEVA HOLDINGS BV·Filed 1994·Granted Oct 10, 2000·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Steven Neville Chatfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →